Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Am Heart J. 2015 Jan 6;169(3):387–395.e3. doi: 10.1016/j.ahj.2014.12.018

Table 5.

Sensitivity analysis showing the predicted Change in Number of atherosclerotic cardiovascular disease (ASCVD) Events and corresponding number needed to treat (NNT) for different moderate intensity statin adherence rates in the MESA newly recommended subcohort.

Event Adherence Rate (Assumed) Estimated Change in # of Event Counts Number Needed to Treat (NNT) 95% Prediction Interval
ASCVD 100% −35.8 48.7 −48.1 −20.0
ASCVD 75% −26.9 64.9 −36.1 −15.0
ASCVD 50% −17.9 97.3 −24.0 −10.0
ASCVD 25% −9.0 194.6 −12.0 −5.0